Abstract The substance P neurokinin 1 receptor (NK 1 R) regulates motility, secretion, inflammation and pain in the intestine. The distribution of the NK 1 R is a key determinant of the functional effects of substance P in the gut. Information regarding the distribution of NK 1 R in subtypes of mouse enteric neurons is lacking and is the focus of the present study. NK 1 R immunoreactivity (NK 1 R-IR) is examined in wholemount preparations of the mouse distal colon by indirect immunofluorescence and confocal microscopy. The distribution of NK 1 R-IR within key functional neuronal subclasses was determined by using established neurochemical markers.
Introduction
The tachykinin family of neuropeptides control motility, secretion, inflammation and pain in the intestine (Steinhoff et al. 2014) . Tachykinins in the intestine, which mainly include substance P (SP) and neurokinin A, derive from intrinsic neurons of the myenteric and submucosal plexuses and from extrinsic neurons of the dorsal root ganglia. Tachykinins from enteric neurons promote peristalsis and secretion of electrolytes and fluid in the intestine Holzer-Petsche 1997a, 1997b) . The tachykinins that are released from the peripheral projections of primary spinal afferent neurons induce neurogenic inflammation of the intestine and the tachykinins that are released from the central projections of these neurons in the dorsal horn of the spinal cord promote visceral nociception (Steinhoff et al. 2014) . These actions of tachykinins are mediated by three neurokinin receptors (NK 1 R, NK 2 R and NK 3 R), which are all expressed within the gastrointestinal tract, with distributions having been best characterised for the guinea-pig ileum (Portbury et al. 1996; Lomax et al. 1998 ). Both NK 1 R and NK 3 R are primarily expressed by neurons of the enteric nervous system (ENS), whereas NK 2 R is predominantly localised to gastrointestinal smooth muscle, nerve varicosities and the epithelium (Holzer and Holzer-Petsche 2001) . Within the ENS, tachykinins acting via NK 3 R stimulate slow excitatory post-synaptic potentials (Bertrand and Galligan 1994) and enhance Na(v)1.9 currents in intrinsic primary afferent neurons (IPANs) of the myenteric plexus (Copel et al. 2009 ). Recent evidence suggests a functional role for neuronal NK 2 R, particularly in mediating contractile responses by the human intestine to electrical field stimulation (Lecci et al. 2006) . The role of neuronal NK 1 R is less-well defined but SP evokes NK 1 Rdependent contractions of the intestine from a number of different species and plays a role in peristalsis (Nieuwmeyer et al. 2006) . NK 1 R is also functionally expressed by intramuscular interstitial cells of Cajal (ICC) and might be involved in mediating the neurogenic effects of SP on gastrointestinal motility (Iino et al. 2004 ). The distribution and neurochemical coding of NK 1 R-immunoreactive enteric neurons has been characterised extensively in the small intestine of the guineapig and rat (Portbury et al. 1996; Mann et al. 1999b ) and, to a lesser extent, in that of the mouse and human (Smith et al. 1998; Vannucchi and Faussone-Pellegrini 2000) . Comparatively fewer studies have examined NK 1 R expression in the colon (Bian et al. 2000; Harrington et al. 2005) , despite its role in controlling spontaneous colonic motility (Lecci et al. 1997; Brierley et al. 2001 ) and water and electrolyte balance (Cooke et al. 1997) and in mediating the proinflammatory effects of SP (Steinhoff et al. 2014) . Moreover, only limited information is available about the neuron-specific distribution of the NK 1 R in the intestine of the mouse (Vannucchi and Faussone-Pellegrini 2000) , despite the wealth of information about the regulation of intestinal motility, secretion, inflammation and pain in this species. Knowledge of the expression of the NK 1 R by subtypes of enteric neurons might provide a mechanistic understanding of the actions of tachykinins within the intestine and might aid in predicting the functional consequences of NK 1 R activation or antagonism.
In this study, we used a well-characterised antibody to NK 1 R combined with established neurochemical markers to characterise the distribution and activation of NK 1 R in the myenteric and submucosal plexuses of the mouse distal colon. We demonstrate NK 1 R expression by myenteric IPANs and submucosal non-cholinergic secretomotor neurons and identify significant interspecies differences in the distribution of NK 1 R. These results provide, for the first time, an anatomical link with the existing literature on the role of the NK 1 R in regulating murine gastrointestinal function.
Materials and methods
Ethical approval All procedures on experimental animals were approved by The Institutional Animal Care and Use Committee of the University of California, San Francisco and the Monash University Animal Ethics Committee.
Animals C57BL/6J mice (6-8 weeks, 20-25 g male and female) were from Charles River Laboratories (Hollister, Calif., USA) or from the Monash Animal Research Platform (Clayton, Victoria, Australia).
Tissue collection Mice were killed by cervical dislocation and the distal colon was collected into cold phosphate-buffered saline (PBS) containing nicardipine (10 μM). Tissues were cleared of contents, opened along the mesenteric border and pinned tautly, mucosa-downwards, onto Sylgard-lined 35-mm dishes. Preparations were then fixed in 4 % paraformaldehyde (in PBS, pH 7.4) overnight at 4°C. To facilitate detection of neuropeptides in the soma of neurons, mice were treated with colchicine (2.5 mg/kg, i.p.) at 6 h prior to tissue collection .
NK 1 R internalisation assays Agonist-induced endocytosis of endogenous NK 1 R and Alexa594-conjugated SP (Alexa-SP) uptake was examined in organotypic preparations of the distal colon as previously described in detail ).
Reagents The following compounds were obtained from the suppliers listed: nicardipine hydrochloride (Sigma-Aldrich, St Louis, Mo., USA), SP (Bachem, Torrance, Calif., USA), RP-67580 (Tocris Bioscience, Ellisville, Mo., USA) and tetrodotoxin citrate (Alomone, Jerusalem, Israel). SP was labelled with Alexa594 dye and purified by high pressure liquid chromatography as described (Bunnett et al. 1995) .
Antibodies A full list of primary antibodies used in this study is provided in Table 1 . Secondary antibodies raised in donkeys were conjugated to Alexa Fluor 488, 594 or 647 (Invitrogen and Jackson Immunoresearch) and used at final dilutions of 1:500 or 1:1000.
Immunofluorescence Myenteric and submucosal wholemounts and tissue sections of the distal colon (12-μm-thick cryosections) were prepared as described and processed for immunofluorescence . Tissues were incubated with primary antisera for 48 h at 4°C in blocking buffer (10 % normal horse serum, 0.1 % Triton X-100 in PBS containing 0.1 % sodium azide). Preparations were mounted in Prolong Gold (Invitrogen) and imaged by using either Zeiss LSM510 META or Leica TCS SP8 confocal microscope systems.
Image analysis Co-expression of NK 1 R with established neurochemical markers was determined manually from Z-stacked confocal images ) and expressed as the percentage overlap between the various neuronal populations. At least three mice were used for the analysis of each marker. The relative distribution of NK 1 R immunoreactivity (-IR) at the cell surface and within the cytosol was determined from captured images by using ImageJ software (NIH) as described .
Results
SP is detected in nerve fibres of extrinsic and intrinsic origin The ENS is the major source of intestinal tachykinins, which derive from cholinergic excitatory motor neurons, ascending interneurons and IPANS of the myenteric plexus and from submucosal IPANS (Furness 2000) . The colon also receives input from tachykinin-expressing primary spinal afferent neurons (Holzer and Holzer-Petsche 1997a) and SP is expressed by immune cells including macrophages and T lymphocytes (Koon and Pothoulakis 2006) .
The distribution of SP-immunoreactive nerve fibres in the distal colon was examined in sections and in myenteric and submucosal whole-mount preparations by using a wellcharacterised antibody that detects tachykinins (Cuello et al. 1979) . In tissue sections, SP-IR was detected in varicose nerve fibres running throughout the inner circular muscle of the muscularis externa and within the myenteric and submucosal ganglia (Fig. 1a, b) . SP-immunoreactive nerve fibres innervating the mucosa were rarely observed (Ekblad et al. 1988; Sang and Young 1996) . SP-positive cells were also present throughout the lamina propria, suggesting expression by immune cells. In addition to its expression in varicose nerve fibres innervating submucosal ganglia, SP-IR was detected in nerve fibres running parallel to submucosal vessels (Fig. 1c) . These fibres were also immunoreactive for calcitonin gene-related peptide (CGRP) and transient receptor potential vanilloid 1 (TRPV1; Fig. 1d ), an observation that is consistent with denervation and anatomical studies that have identified these as being of extrinsic origin (Costa et al. 1981; Ekblad et al. 1988; Galligan et al. 1988) . SP-immunoreactive fibres within submucosal ganglia were often detected independently of CGRP-IR. In contrast, the majority of CGRPpositive fibres were also SP-immunoreactive. SP-IR is a marker of submucosal IPANs (Bornstein et al. 1989; Kirchgessner et al. 1992) . SP-IR was not detected in submucosal neurons, consistent with evidence that no submucosal IPANs are present in the mouse ileum and colon (Fig. 1e, f; Sang and Young 1996; Wong et al. 2008; Mongardi Fantaguzzi et al. 2009 ) and with studies demonstrating that SP-immunoreactive fibres innervating submucosal ganglia are of myenteric origin (Jessen et al. 1980; Costa et al. 1981) .
In myenteric whole-mount preparations, SP-positive fibres were dense throughout the myenteric ganglia and also ran within and parallel to the circular muscle layer. No overlap occurred between the SP-and CGRP-positive varicosities in either region (Fig. 1g, h ). As SP and CGRP are expressed by distinct functional subpopulations of myenteric neurons (Qu et al. 2008) , this suggests that these fibres are of intrinsic origin. SP-positive fibres were also detected in wholemounts of the submucosal ganglia in which they were less numerous than within myenteric ganglia. These results confirm that the endogenous NK 1 R agonist SP is expressed in discrete regions of the colon wall and further extends these studies to define the distribution of SP-positive nerve fibres within the enteric ganglia of the mouse colon.
NK 1 R is expressed by enteric neurons of the distal colon In sections of the distal colon, NK 1 R-IR was detected in enteric ganglia ( Fig. 1b ) and in colonocytes (not shown). Weak NK 1 R-IR was also found in smooth muscle of the muscularis externa. Within enteric neurons, NK 1 R-IR was localised to the plasma membrane of the soma and neurites, with minimal intracellular stores. This was particularly evident for submucosal neurons in which the majority of NK 1 R-IR was cellsurface-associated. In submucosal whole-mount preparations, NK 1 R-IR was expressed by the majority of all neurons in all ganglia examined. No NK 1 R-IR was detected in fibres that were associated with the submucosal vasculature or lymphatics ( Fig. 1c-f ). NK 1 R-IR was localised to a subset of large-diameter, multi-and unipolar myenteric neurons (Fig. 1g) . NK 1 R-IR was also present in ICCs within the myenteric and intramuscular levels, although this staining Fig. 1 Distribution of neurokinin 1 receptor (NK 1 R) and its endogenous agonist substance P (SP) in the mouse distal colon. a, b SP immunoreactivity (-IR) was detected in enteric ganglia and in nerve fibres within the inner circular muscle layer (arrowheads). SP-positive cells were also detected throughout the mucosa (arrows; lm longitudinal muscle layer, cm circular muscle layer, mp myenteric plexus). c-h NK 1 R-IR was mainly localised to submucosal (c, e, f) and myenteric (b, g, h) neurons. c, d SP-IR was detected in nerve fibres associated with submucosal arterioles (star, arrowheads with stars) and submucosal ganglia (box). d SP-immunoreactive FIBRES innervating arterioles (star) were also immunoreactive for calcitonin gene-related peptide (CGRP) and transient receptor potential vanilloid 1 (TRPV1; arrowheads). e, f SP-IR (arrowheads with stars) was often closely associated with NK 1 R-positive submucosal neurons and expression was largely distinct to CGRP-immunoreactive varicosities (arrows). Coexpression of SP-IR and CGRP-IR is indicated by arrowheads. g NK 1 R-immunoreactive myenteric neurons were generally large and often multipolar. SP-IR (arrowheads with stars) and CGRP-IR (arrows) occurred in distinct fibres and varicosities. Bars 50 μm (a, b), 20 μm (c-h) was weak relative to that of neurons and to other regions of the gut (not shown). No evidence was obtained for NK 1 R staining of enteric glial cells, as identified by double-labelling against the glial marker glial fibrillary acidic protein (not shown).
NK 1 R-IR is expressed by non-cholinergic submucosal secretomotor neurons Although good physiological evidence indicates that the activation of NK 1 R on submucosal neurons leads to their depolarisation and to enhanced secretomotor activity (MacNaughton et al. 1997) , the neuronal subtypes that express NK 1 R in these ganglia remain largely undefined. We examined the distribution and neurochemical coding of NK 1 R-immunoreactive neurons in submucosal ganglia of the mouse distal colon. Prominent NK 1 R-IR was detected in the majority of protein gene product 9.5 (PGP9.5)-immunoreactive submucosal neurons (86 %, 248/288 neurons) in which it was localised to the plasma membrane of the soma and neurites ( Fig. 2a-a" ). Where neurites were clearly visible, these neurons were generally unipolar and had smooth cell bodies. Neurons with extremely weak staining intensity or no detectable staining were considered to be negative for NK 1 R-IR for the purposes of this study. The NK 1 R-immunoreactive population was further characterised by using established neurochemical markers for various neuronal subtypes present in the murine submucosal plexus (Mongardi Fantaguzzi et al. 2009 ). All NK 1 R-immunoreactive neurons were calretininimmunoreactive (100 %, 143/143 neurons), whereas 84 % of calretinin-positive neurons (143/170 neurons) were also NK 1 R-immunoreactive (Fig. 2b-b" ). All NK 1 R-immunoreactive neurons were vasoactive intestinal polypeptide (VIP)-immunoreactive (99 %, 170/171 neurons; Fig. 2c-c") . Most NK 1 R-immunoreactive neurons were neuropeptide Y (NPY)-immunoreactive ( Fig. 2d-d") , indicating that, as in the ileum, extensive overlap between the VIP-immunoreactive and NPYimmunoreactive subpopulations of neurons also occurs in the distal colon of the mouse. The extensive colocalisation between IR for neurofilament M (NFM) and NK 1 R (not quantified; Fig. 3d-d") suggests that NFM is mainly expressed by non-cholinergic secretomotor neurons. In contrast, overlap was minimal between NK 1 R-IR and either choline acetyltransferase (ChAT)-IR (1 %, 2/275 neurons; Fig. 2e -e") or somatostatin (0 %, 1/225 neurons; Fig. 2f-f") , which are specifically localised to cholinergic secretomotor neurons (De Jonge et al. 2003; Mongardi Fantaguzzi et al. 2009 ). These neurons were relatively lower in abundance than those positive for VIP or NPY. Similarly, almost no overlap was seen between NK 1 R and CGRP, with only 2 % of the NK 1 R population also being immunopositive for CGRP (1/54 neurons; Fig. 3a-a") . CGRP is an established marker of AH neurons in other species and is expressed by submucosal cholinergic secretomotor neurons of the mouse (Mongardi Fantaguzzi et al. 2009 ). SP, another potential IPAN marker, was not detected within the somata of submucosal neurons, although an extensive network of SP-immunoreactive varicosities was closely associated with NK 1 R-immunoreactive neurons (Fig. 1e, f) . NK 1 R-IR and nitric oxide synthetase (NOS)-IR were often present in the same neurons and 29 % (56/196 neurons) of all NK 1 R-immunoreactive neurons were also NOS-immunoreactive (Fig. 3b-b") . In contrast to the ileum (Mongardi Fantaguzzi et al. 2009) , no tyrosine-hydroxylasepositive neurons were detected in submucosal ganglia by using the same antibody (0/64 neurons, 3 mice) and IR was restricted to nerve fibres associated with ganglia and the submucosal vasculature (Wong et al. 2008 ; Fig. 3c-c") . All counts are summarised in Table 2 . In summary, NK 1 R-IR is expressed by most submucosal neurons of the mouse distal colon. NK 1 Rimmunoreactive neurons have the neurochemical composition of non-cholinergic secretomotor neurons.
NK 1 R-IR is expressed by myenteric intrinsic primary afferent neurons Tachykinins released from SP-positive circular muscle motor neurons regulate migrating motor complexes in the colon (Foxx-Orenstein and Grider 1996; Brierley et al. 2001; Mule et al. 2007 ) and mediate a non-cholinergic component of the peristaltic reflex (Holzer and Holzer-Petsche 1997a; Lecci et al. 1997) . Although these studies predict that NK 1 R is expressed by cholinergic and nitrergic neurons of the colon (Mule et al. 2007) , an in-depth analysis of NK 1 R expression by myenteric neurons in this region is lacking.
NK 1 R-IR was present in a subset of PGP9.5-immunoreactive myenteric neurons of the distal colon (22 %, 152/684, Fig. 4a-a") . These neurons were large and multipolar and had prominent neurites. NK 1 R-IR was detected at the plasma membrane of the soma and neurites, with comparatively little cytosolic staining. Double-labelling by using markers of IPANs (Furness et al. 2004b ) indicated that 76 % (59/78 neurons) of NK 1 R-immunoreactive neurons were also CGRP-immunoreactive ( Fig. 4b-b" ) and that many of these were also immunoreactive for NFM (not quantified), which enables observation of neuronal morphology (Fig. 4c-c" ; Qu et al. 2008) . Nearly all NK 1 R-immunoreactive neurons coexpressed calretinin-IR (95 %, 124/130 neurons, Fig. 4d-d") , a putative marker of IPANs and other neurons in the mouse (Furness et al. 2004a; Qu et al. 2008 ) and rat (Mann et al. 1997) . Moreover, extensive colocalisation also occurred with ChAT-IR (88 %, 118/134 neurons; Fig. 5a-a") . The remaining NK 1 R-immunoreactive neurons were NOSimmunoreactive (9 %, 21/230 neurons; Fig. 5b-b") . No overlap between NK 1 R-IR and SP-IR was observed (0 %, 0/71 neurons; Fig. 5c-c") . Internalisation of Alexa-SP was used to identify NK 1 R-expressing neurons (Jenkinson et al. 1999) , allowing examination of the overlap between NK 1 R and markers for which only rabbit antibodies were available. Little colocalisation was seen between NK 1 R (detected by internalisation of Alexa-SP, 100 nM, 30-min treatment) and the somatostatin 2A receptor (SSTR2A), a mediator of the descending inhibitory component of the peristaltic reflex (Grider 2003 ; not shown). The majority of SSTR2A-immunoreactive neurons were Alexa-SP-negative (88 %, 21/ 24 neurons), consistent with the localisation of SSTR2A to NOS-immunoreactive neurons (Zhao et al. 2013) . Similarly, most Alexa-SP-positive neurons were negative for SSTR2A-IR. All counts are summarised in Table 3 . In summary, our data indicate that NK 1 R-IR in the myenteric plexus of the mouse distal colon is largely restricted to IPANs. NK 1 R is functionally expressed by submucosal neurons To assess the activation of the NK 1 R in submucosal neurons, we examined agonist-stimulated endocytosis of the NK 1 R. Previous studies have utilised endocytosis as an indicator of receptor activation in endothelial cells and neurons (Bowden et al. 1994; Marvizon et al. 1997) . Treatment with Alexa-SP (100 nM, 30 min) resulted in the presence of Alexa-SPpositive endosome-like structures throughout the soma and neurites of both submucosal and myenteric neurons (Fig. 6a,  a' ). These possible endosomes were also NK 1 R-immunoreactive, indicating that the internalisation of both receptor and agonist had occurred (Fig. 6b-b") . Alexa-SP labelling was restricted to the cell surface of the soma and neurites following Alexa-SP binding at 4°C without warming, a temperature at which endocytosis is significantly inhibited (Grady et al. 1996) . Neither the endocytosis of NK 1 R-IR nor the uptake of Alexa-SP was observed following prior treatment with the NK 1 R antagonist RP-67580 (10 μM, not shown), a concentration that effectively abolishes NK 1 R-dependent signalling in enteric neurons . Neurons with Alexa-SP-labelled endosome-like structures were NK 1 R-immunoreactive and were also immunoreactive for NPY or ChAT (submucosal plexus and myenteric plexus, respectively, not shown). Internalisation of submucosal NK 1 R-IR in response to unlabelled SP was concentration-dependent (100 pM to 1 μM). Significant receptor endocytosis relative to untreated controls was detected at concentrations of 1 nM and greater (Fig. 6c-c"", d) . Thus, we conclude that NK 1 R is functionally expressed by submucosal neurons of the mouse distal colon and that the antibody that we used specifically detects NK 1 R-IR in mouse tissues.
Discussion
The functional subtypes of enteric neurons can be readily identified by their neurochemical content, morphology and projections. These neurons have been comprehensively categorised in the guinea-pig ileum (Costa et al. 1996) . However, despite the wealth of information about pathophysiological processes in the intestine of the mouse, the neurochemical characterisation of murine enteric neurons is incomplete (Sang and Young 1996; Sang et al. 1997; Qu et al. 2008; Mongardi Fantaguzzi et al. 2009 ). To provide a mechanistic understanding of the functions of the NK 1 R in this species, we completed a comprehensive study of the localisation of the NK 1 R in enteric neurons of the mouse colon.
NK 1 R is expressed by myenteric IPANs, descending interneurons and inhibitory motor neurons Our results show that the NK 1 R is expressed by myenteric IPANs, descending interneurons and inhibitory motor neurons of the mouse distal colon. Expression of NK 1 R by myenteric IPANs is supported by the following observations. NK 1 R-immunoreactive neurons were morphologically defined as Dogiel Type II based on their large round cell bodies and the presence of multiple axons. Moreover, NK 1 R-IR was generally coexpressed with the established IPAN marker CGRP (Grider 1994; Furness et al. 2004b) . Extensive colocalisation also occured between NK 1 R-IR and the neurochemical markers NFM and calretinin, which are expressed by IPANs and other neurons in the mouse myenteric plexus (Furness et al. 2004b; Qu et al. 2008) . IPANs are cholinergic (Furness et al. 2004a ) and, accordingly, the majority of NK 1 R-immunoreactive neurons were also ChATpositive. The remaining neurons were most likely to be inhibitory motor neurons and descending interneurons. This conclusion is based on the overlap with NOS-IR and SSTR2A-IR and on the presence of NK 1 R-immunoreactive neurons that were ChAT-negative. The colocalisation between NK1R-IR and somatostatin-IR is consistent with the expression of NK 1 R-IR by at least one class of descending interneuron (Costa et al. 1996; Grider 2003) . These are medium-sized neurons that are also ChAT-immunoreactive (De Jonge et al. 2003; Qu et al. 2008) . The lack of apparent overlap between NK 1 R-IR and SP-IR precludes expression by ascending interneurons, as these are tachykininergic in both mouse and guinea-pig small intestine (Qu et al. 2008) .
NK 1 R is expressed by submucosal non-cholinergic secretomotor/vasodilator neurons Relatively few studies Fig. 4 NK 1 R-IR is primarily localised to myenteric intrinsic primary afferent neurons of the colon. a-a" NK 1 R-IR was expressed by relatively largediameter PGP9.5-immunoreactive neurons, which were often multipolar (arrowheads). Extensive overlap (arrowheads) was detected between NK 1 R-IR and the putative intrinsic primary afferent neuron (IPAN) markers CGRP (b-b"), NFM (c-c") and calretinin (d-d") . Arrowheads with stars indicate no overlap. Bars 20 μm have been carried out on the neurochemical composition of murine submucosal neurons (Sang and Young 1996; Mongardi Fantaguzzi et al. 2009; Poole et al. 2011) . Our results indicate that NK 1 R-IR is exclusively expressed by non-cholinergic secretomotor neurons. Support for this conclusion is based on two lines of evidence. First, all NK 1 Rimmunoreactive neurons of the submucosal plexus of the mouse colon also expressed VIP, which is a marker of noncholinergic secretomotor submucosal neurons and which is conserved across multiple species, including humans (Porter et al. 1999) . Thus, the NK 1 R-IR is exclusively expressed by non-cholinergic secretomotor submucosal neurons. Moreover, nearly all VIP-immunoreactive neurons were also NK 1 R-positive. Secondly, no overlap occurs between NK 1 R-IR and IR for ChAT, somatostatin or CGRP, all of which are markers of cholinergic neurons in mouse submucosal ganglia (Sang and Young 1996; De Jonge et al. 2003; Mongardi Fantaguzzi et al. 2009 ). In the mouse ileum, the VIPpositive population can be further subdivided into secretomotor and vasodilator neurons based on their expression of tyrosine hydroxylase (TH; Mongardi Fantaguzzi et al. 2009 ). An equivalent characterisation of NK 1 R-immunoreactive neurons in the distal colon was not possible, as we were unable to detect TH-positive submucosal neurons in this region by using an identical antibody. TH-IR in these preparations was restricted to nerve fibres associated with the submucosal vasculature and ganglia (Wong et al. 2008) . This is in accordance with the significantly lower population of THpositive neurons in the submucosal ganglia of the distal colon relative to other regions (Chalazonitis et al. 2011 ).
Distribution of NK 1 R differs markedly between species The findings of this study highlight the clear differences between the distributions of NK 1 R-IR in the guinea-pig, rat and mouse. In submucosal ganglia of the guinea-pig ileum, the NK 1 R-IR is primarily localised to secretomotor neurons containing NPY-IR and ChAT-IR (Portbury et al. 1996; Moore et al. 1997; Lomax et al. 1998 ). In the guinea-pig colon, the majority of NK 1 R-immunoreactive submucosal neurons are cholinergic, with expression in other neuron types including IPANs (Harrington et al. 2005) . These findings are consistent with the distribution predicted by functional studies of tachykininmediated chloride secretion and neuron depolarisation (Frieling et al. 1999 ). In the rat distal colon, the NK 1 R colocalises with SP in Dogiel type II submucosal neurons (Mitsui 2010 ).
The present results clearly demonstrate that the NK 1 R is expressed by non-cholinergic secretomotor neurons in the submucosal plexus of the mouse distal colon. Previous studies (Wong et al. 2008; Mongardi Fantaguzzi et al. 2009; Poole et al. 2011 ) and the present results show that, in marked contrast to the guinea-pig and rat, extensive overlap occurs between NPY-and VIP-positive neuronal populations, with little evidence for submucosal IPANs in the mouse colon. This relative structural simplicity of the mouse submucosal plexus might underlie the differences in NK 1 R distribution that we observe. Whether these differences translate to species-specific differences in SP-mediated neurogenic control of fluid and electrolyte secretion in the intestine remains to be determined. In the myenteric plexus of the guinea-pig ileum, the NK 1 R is mainly expressed by NOS-immunoreactive inhibitory motor neurons, with excitatory motor neurons, secretomotor neurons and a minor proportion of IPANs making up the remaining NK 1 R-positive neuronal population (Lomax et al. 1998 ). In the guinea-pig distal colon, comparatively fewer NK 1 Rimmunoreactive myenteric neurons can be found and these co-express NOS, ChAT or calbindin (Bian et al. 2000; Harrington et al. 2005) . The distribution of the NK 1 R in the rat ileum differs from that of the guinea-pig, with the NK 1 R being localised to myenteric IPANs (Mann et al. 1997 ) and often coexpressed with SP (Mann et al. 1999a; Mitsui 2011) . Based on these studies, our data suggest that the distribution of NK 1 R in the myenteric plexus of the mouse colon is most similar to that in the rat.
Few studies have examined the distribution of NK 1 R in the human ENS, probably because of a lack of suitable means of detection. Immunohistochemical and in situ hybridisation studies show that the NK 1 R is expressed by enteric neurons of the human antrum, duodenum and colon (Smith et al. 1998 (Smith et al. , 2000 Goode et al. 2000; Boutaghou-Cherid et al. 2006 ). Functional studies demonstrate that the NK 1 R mediates nonadrenergic non-cholinergic neuromuscular transmission to the circular muscle of the human ileum (Zagorodnyuk et al. 1997) and regulates neurogenic contractions of the isolated colon (Cellek et al. 2006; Guagnini et al. 2006) .
Functional implications of NK 1 R distribution in inflammatory bowel disease Myenteric NK 1 R is unlikely to play a role in enhanced nociceptive signalling from the colon, such as occurs in irritable bowel syndrome (IBS) or inflammatory bowel disease (IBD). The neurons identified as NK 1 R-positive in the present study do not project centrally and are therefore not involved in the transduction of noxious stimuli to the spinal cord. Although NK 1 R is expressed by dorsal root ganglion neurons (Zhang et al. 2007) , whether colonic primary spinal afferents are NK 1 R-positive is presently unknown.
An increased capsaicin-evoked SP release occurs from extrinsic nerve fibres innervating the colon in experimental colitis. Mice deficient in SP have reduced inflammation following dextran sulphate sodium treatment relative to wild-type mice (Engel et al. 2012) . Furthermore, the extrinsic denervation or pharmacological inhibition of NK 1 R also significantly attenuates experimental colitis (Castagliuolo et al. 2002; Landau et al. 2007; Gad et al. 2009 ). NK 1 R expression is upregulated in the colon of patients with IBD (Goode et al. 2000) and in animal models of colitis (Kimball et al. 2007 ). The internalisation of NK 1 R is indicative of the localised release of SP at sites of inflammation (Bowden et al. 1994) . The increased release of SP in IBD is supported by our own preliminary data showing that myenteric NK 1 R is largely internalised in a model of chronic colitis (Cattaruzza et al. 2013 ). This would effectively prevent NK 1 R from signalling at the cell surface and is consistent with a loss of neuronal NK 1 R function in IBD (Smith and Smid 2005) and experimental colitis (Hosseini et al. 1999) and to a reduction in gastrointestinal tachykininergic signalling in general (Al-Saffar and Hellstrom 2001). We report that myenteric NK 1 R-IR is mostly expressed by neurochemically defined IPANs. These neurons determine the magnitude and type of reflexes that are initiated by various stimuli, with intestinal inflammation leading to their hyperexcitability (Furness et al. 2004a ). The functional consequences of inflammation on NK 1 R-dependent signalling by these neurons are presently unknown. As IPANs are key integrators of reflex activity, effective blockage of NK 1 R signalling through internalisation could potentially affect all physiological reflexes mediated by the myenteric plexus, including coordinated motility patterns.
The NK 1 R is involved in secretory reflex pathways in the intestine and has a potential role in toxin-induced hypersecretion. NK 1 R has a pro-secretory role in the intestine, as determined pharmacologically by using NK 1 R-selective antagonists (Frieling et al. 1999; Riegler et al. 1999) . In the present study, we identified VIP-positive non-cholinergic secretomotor/vasodilator neurons as the major NK 1 R-immunoreactive population. Activation of NK 1 R expressed by these neurons would be expected to promote secretion. NK 1 R antagonists attenuate cholera-associated hypersecretion (Turvill et al. 2000) and suppress cholera-toxin-induced hyperexcitability of submucosal neurons (Gwynne et al. 2009 ). Internalisation of NK 1 R in enteric neurons occurs following exposure to Toxin A, the causative agent of Clostridium difficile-induced ileitis. Toxin A stimulates the release of SP from afferent fibres and the activation of NK 1 R, whereas genetic deletion of NK 1 R prevents Toxin-A-induced tissue damage (Mantyh et al. 1996) .
Concluding remarks In summary, we described the neurochemical coding of NK 1 R-immunoreactive neurons in the mouse distal colon. We discussed the neuronal subtypes by which this receptor is expressed and the differences in NK 1 R distribution across commonly used laboratory species. The findings of this work will directly relate to physiological studies of the role of NK 1 R in the gut and the effects that drugs targeting NK 1 R activity have on colonic motility and secretion.
